Sundaram Clayton Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
SUNCLAY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sundaram Clayton reported Q1 FY26 standalone revenue from operations of Rs. 442.1 Cr, down from Rs. 549 Cr a year ago, mainly because the Hosur business was sold off in Q4 FY25. Despite the lower top line, standalone EBITDA grew about 16% to Rs. 70.6 Cr, with operating margin improving sharply to 15.5% from 10.3% a year ago. Standalone profit after tax was nearly flat at Rs. 17 Cr (EPS Rs. 7.72). On a consolidated basis, the company slipped into a loss of Rs. 57.8 Cr versus Rs. 55.9 Cr loss last year, dragged down by Rs. 75.5 Cr of losses in 5 overseas subsidiaries. The company invested Rs. 77.3 Cr in its US subsidiary during the quarter, and US operations posted their highest-ever quarterly sales of Rs. 79.7 Cr, up 32% YoY. CRISIL rating remains AA-/Negative.
Standalone earnings show healthy margin expansion and stable profit despite a smaller revenue base, which is positive. However, the consolidated loss, weak North American market commentary, and continued AA-/Negative credit rating outlook may keep investors cautious in the near term.